企業プロフィール

Teladoc 株価・ニュース・カタリスト

ティッカー:
TDOC
取引所:
NYSE
セクター:
Biopharma
所在地:
United States

株価パフォーマンス

6.54 USD (-3.96%)

終値

最終更新: 2026年8月17日

1.36B USD

時価総額

株価変動の要因

As of Aug 17, 2026, TDOC closed down 3.96% at $6.54. No new same-company headline was identified in the current news window.

企業概要

Global Virtual Care Platform

Teladoc Health is a global virtual care company that connects patients, providers, platforms, health plans, employers, health systems, and consumers. Its model is built around expanding access, supporting provider capacity, improving outcomes, and reducing healthcare costs through digital care delivery.

Integrated Care Segment

Integrated Care includes virtual medical services such as general medical care, expert medical services, specialty medical care, chronic condition management, mental health, enabling technologies, and enterprise telehealth solutions. This segment was more stable in the second quarter of 2026, with revenue growth and margin performance above the midpoint of company guidance.

BetterHelp Segment Transition

BetterHelp provides virtual therapy and wellness services globally. The segment is shifting from a cash-pay-heavy model toward insurance-covered services, reflecting consumer preference for insurance coverage. Demand for insurance-covered services exceeded available provider capacity in the quarter, while cash-pay pressure accelerated, leading the company to lower BetterHelp revenue expectations.

Strategic Position

Teladoc is best understood as a two-segment virtual care company. Integrated Care provides enterprise and health-plan-oriented stability, while BetterHelp offers large behavioral health exposure but is undergoing a business model transition. The company's near-term profile depends on improving BetterHelp capacity and insurance conversion while maintaining Integrated Care margins and product innovation.

今後のカタリスト

  • Teladoc's catalysts are BetterHelp monetization, integrated-care growth, and whether chronic-care utilization can support a cleaner margin profile. The market will care about whether the company can turn a broad telehealth base into repeatable operating leverage rather than one more quarter of mixed usage.

最近のニュース

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

類似銘柄

事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。